Kyprolis
Term · Oncology and biomedicine · MLC-T-ONC-004678
A drug used alone or with other drugs to treat adults with multiple myeloma that came back or did not get better after treatment with one or more other therapies. It is also being studied in the treatment of other types of cancer. Kyprolis blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called carfilzomib.
| Identifier | MLC-T-ONC-004678 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | carfilzomib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004678",
"term": "Kyprolis",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with other drugs to treat adults with multiple myeloma that came back or did not get better after treatment with one or more other therapies. It is also being studied in the treatment of other types of cancer. Kyprolis blocks the action of enzymes called proteasomes, which may help keep cancer cells from growing and may kill them. It is a type of proteasome inhibitor. Also called carfilzomib.",
"synonyms": [
"carfilzomib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/kyprolis/"
}
Record 9,852 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.